Herceptin SC is given as a subcutaneous injection (under the skin) over 2 to 5 minutes every three weeks. More instructions can be found in Section 4. How do I use Herceptin SC? in the full CMI.

plus Herceptin (trastuzumab) for subcutaneous injection (SC) versus Perjeta plus Herceptin for SC and optional physician's choice of endocrine therapy as a maintenance treatment in HER2-positive ...

Subcutaneous administration of trastuzumab and pertuzumab significantly shortened the time patients with stage I ...

Before that, the Swiss pharma owned part of the company and held marketing rights outside the US to Herceptin as well as other Genentech drugs. Typically, the volume of a subcutaneous injection is ...

An oncologist from Atrium Health outlines how saving time administering immunotherapy could have far-reaching benefits.

Too many copies of the HER2 gene or its overexpression appeared to cause an especially aggressive form of the disease. By the late ’90s, a drug called Herceptin that targeted the HER2 receptor, sped ...

Phesgo combines the anti-HER2 antibodies in Herceptin (trastuzumab) and Perjeta (pertuzumab) in a subcutaneous injection that takes a few minutes to deliver. At the moment, Herceptin is available ...

Phesgo comes in a single-dose vial and can be dosed as a subcutaneous injection, while at the moment breast cancer patients the two anti-HER2 drugs separately receive Herceptin as a subcutaneous ...

Herceptin SC administration reduces delivery ... HyQvia is administered as a single monthly SC injection for the majority of patients, compared with weekly multisite injections required for ...

an injection for SC administration of testosterone replacement therapy; and ATRS-1902, a proprietary drug device combination product. The company offers Herceptin (trastuzumab), Herceptin Hylecta ...